An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

Glioblastoma (GBM) is the most common primary malignant brain tumor. Nomograms are often used for individualized estimation of prognosis. This study aimed to build and independently validate a nomogram to estimate individualized survival probabilities for patients with newly diagnosed GBM, using dat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuro-oncology (Charlottesville, Va.) Va.), 2017-05, Vol.19 (5), p.669-677
Hauptverfasser:	Gittleman, Haley, Lim, Daniel, Kattan, Michael W, Chakravarti, Arnab, Gilbert, Mark R, Lassman, Andrew B, Lo, Simon S, Machtay, Mitchell, Sloan, Andrew E, Sulman, Erik P, Tian, Devin, Vogelbaum, Michael A, Wang, Tony J C, Penas-Prado, Marta, Youssef, Emad, Blumenthal, Deborah T, Zhang, Peixin, Mehta, Minesh P, Barnholtz-Sloan, Jill S
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemoradiotherapy - mortality Clinical Investigations Female Follow-Up Studies Glioblastoma - mortality Glioblastoma - pathology Glioblastoma - therapy Humans Karnofsky Performance Status Male Medical Oncology Middle Aged Nomograms Prognosis Randomized Controlled Trials as Topic Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!